Generic · Injection · Updated Nov 11, 2026
Midazolam 1 mg/mL injection price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for midazolam 1 mg/ml injection and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Midazolam 1 mg/mL price history
What pharmacies pay for 50 mL, weekly- Now
- $11.53
- 52-week low
- $11.53
- 52-week high
- $12.04
- A year ago
- $11.69
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $0.2334 | $0.2305 | -1.2% | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $0.2343 | $0.2334 | -0.4% | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $0.2339 | $0.2343 | +0.2% | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $0.2305 | $0.2339 | +1.5% | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $0.2313 | $0.2305 | -0.3% | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $0.2345 | $0.2313 | -1.4% | pharmacies' invoice prices changed (survey) |
| Apr 22, 2026 | $0.2400 | $0.2345 | -2.3% | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $0.2408 | $0.2400 | -0.3% | pharmacies' invoice prices changed (survey) |
Prices per mL. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for midazolam 1 mg/ml injection
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Shortages
- Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2305-50)Next Delivery: December 2027; Estimated Recovery: March 2028; Shortage per Manufacturer: Manufacturing Delay
- Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05)Next Delivery: January 2027; Estimated Recovery: March 2027
- Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02)Next Delivery: December 2026; Estimated Recovery: March 2027
- Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2308-49)
- Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03)
- Midazolam Hydrochloride, Injection, 10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2308-50)
- Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)Next Estimated Delivery and Estimated Recovery: December 2026
- Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25)Limited Supply Available. Next Delivery: December 2026; Estimated Recovery: June 2027
- Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)Next Delivery and Estimated Recovery: December 2026
- Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027
- Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05)
- Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25)Next release November 2026. Check wholesalers for inventory.
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 43 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
4 companies sell midazolam 1 mg/ml injection under 6 package codes (NDCs). Pharmacies pay the same per mL whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| Fresenius Kabi USA, LLC | 63323-411-12 | $0.2305 |
| Hikma Pharmaceuticals USA Inc. | 0641-6057-25 0641-6209-25 | $0.2305 |
| A-S Medication Solutions | 50090-5472-0 | - |
| Henry Schein, Inc. | 0404-9913-05 0404-9780-10 | - |
All 6 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other midazolam strengths and forms
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 14.3 mg/mL, 0.7 mL auto-injector | Not priced this week | |||
| 1 mg/mL, 2 mL injection | $0.2305 | $11.53 / 50 mL | ||
| 5 mg/mL injection | $0.3817 | $38.17 / 100 mL | ||
| 5 mg/mL, 1 mL injection | $1.22 | $12.20 / 10 mL | ||
| 5 mg/mL, 2 mL injection | $0.5662 | $11.32 / 20 mL | ||
| 2 mg/mL oral solution | $0.6221 | $73.41 / 118 mL | ||
Official label & what changed
These highlights do not include all the information needed to use MIDAZOLAM INJECTION safely and effectively. See full prescribing information for MIDAZOLAM INJECTION. MIDAZOLAM injection, for intramuscular use, CIV Initial U.S. Approval: 1985
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Monitor patients for respiratory depression and sedation [see Warnings and Precautions (5.1), Drug Interactions (7.1)].
The use of benzodiazepines, including midazolam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing Midazolam Injection and throughout treatment, assess each patient's risk for abuse, misuse, and addiction [see Warnings and Precautions (5.2)].
The continued use of benzodiazepines may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Although Midazolam Injection is indicated only for intermittent use [see Indications and Usage (1) and Dosage and Administration (2)], if used more frequently than recommended, abrupt discontinuation or rapid dosage reduction of Midazolam Injection may precipitate acute withdrawal reactions, which can be life-threatening. For patients using Midazolam Injection more frequently than recommended, to reduce the risk of withdrawal reactions, use a gradual taper to discontinue Midazolam Injection [see Warnings
and Precautions (5.3)].
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND
WITHDRAWAL REACTIONS
See full prescribing information for complete boxed warning.
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Monitor patients for respiratory depression and sedation. (5.1, 7.1)
The use of benzodiazepines, including midazolam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Before prescribing Midazolam Injection and throughout treatment, assess each patient's risk for abuse, misuse, and addiction. (5.2)
Although Midazolam Injection is indicated only for intermittent use (1, 2), if used more frequently than recommended, abrupt discontinuation or rapid dosage reduction of Midazolam Injection may precipitate acute withdrawal reactions, which can be lifethreatening. For patients using Midazolam Injection more frequently than recommended, to reduce the risk of withdrawal reactions, use a gradual taper to discontinue Midazolam Injection. (5.3)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about midazolam 1 mg/ml injection
How much does midazolam 1 mg/ml injection cost without insurance?
Pharmacies pay about $11.53 for 50 mL ($0.2305 per mL) as of November 11, 2026. A fair cash price is about $23.76: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $23.26 including shipping.
Is my price for midazolam 1 mg/ml injection fair?
Compare it with the fair cash price of $23.76 for 50 mL. Up to about $29.70 is fair; above $47.52 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is midazolam 1 mg/ml injection getting more expensive?
Over the last four weeks the price pharmacies pay fell 1.2%. Over a year it fell 1.4%. See the 52-week chart.
Who makes midazolam 1 mg/ml injection?
4 companies: Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA Inc., A-S Medication Solutions, Henry Schein, Inc.. See every package code.
Is midazolam in shortage?
Yes - 30 products are listed as short or being discontinued. Details.
Has midazolam been recalled?
43 recalls on record, 3 ongoing. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about midazolam 1 mg/ml injection
No comments yet. Questions, tips, what worked for you - start the conversation.